Dr. Biljana Horn collaborates with Dr. Lung-Ji Chang to bring chimeric antigen T-cell therapy, a very effective form of immunotherapy to patients

Dr. Giselle Moore-Higgs, manages Clinical Trials portfolio with over 30 therapeutic pediatric cancer trials and 23 additional studies involving cancer biology and survivorship.

  • $250,000 committed in 2018 was renamed the Stop Children’s Cancer / Kimberly H. Flaitz Research Grant providing seed funding for Dr. Matthew Cascio in developing a tumor vaccine for osteosarcoma. Kimberly passed away from osteosarcoma in 1998 at age of 24.
  • $100,000 Lyrics for Life / Stop Children’s Cancer Jeffrey A. Block Research Award will fund Dr. Paul Castillo. He is working to develop personalized targeted immunotherapy for T-cell lymphoma and leukemia. Jeffrey passed away from T-cell lymphoma in 1987 at age of 18.